Larin Fe 1.5/30 Kit
Product Images NDC 16714-405

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Larin Fe 1.5/30 (NDC 16714-405). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

Chemical structures of the active ingredients Norethindrone Acetate and Ethinyl Estradiol as shown in the image for the product Larin Fe 1.5/30 kit by Northstar Rx LLC.*

FDA Label Image

2 (Image 02)

A table showing the lowest expected and typical failure rates during the first year of continuous use of various contraceptive methods, including no contraception, oral contraceptives, diaphragm, spermicides, vaginal sponge, implants, injections, IUDs, condoms, cervical cap, periodic abstinence, withdrawal, and sterilization. The table lists the percentage of women experiencing unintended pregnancy for each method.*

FDA Label Image

3 (Image 03)

A text panel warning about the increased risk of serious cardiovascular side effects from oral contraceptive use associated with cigarette smoking, highlighting higher risk in women over 35 and heavy smokers (15 or more cigarettes per day), advising women using oral contraceptives not to smoke.*

FDA Label Image

4 (Image 04)

A bar chart titled 'TABLE II Circulatory Disease Mortality Rates per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use.' It shows mortality rates for age groups 15–24, 25–34, 35–44, and 45 and older, categorized by smoking status and oral contraceptive use with distinct bar patterns and colors representing ever-users and controls among smokers and non-smokers.*

FDA Label Image

5 (Image 05)

A table showing the annual number of birth-related or method-related deaths per 100,000 nonsterile women by fertility control method and age group. Methods listed include no fertility control, oral contraceptives for smokers and non-smokers, IUD, condom, diaphragm/spermicide, and periodic abstinence, with death rates categorized by age from 15-19 to 40-44 years.*

FDA Label Image

6 (Image 06)

A warning text panel stating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, with risk increasing with age and heavy smoking (15 or more cigarettes per day), particularly marked in women over 35 years of age, advising women who use oral contraceptives not to smoke.*

FDA Label Image

7 (Image 07)

An instructional diagram for the Larin Fe 1.5/30 kit illustrating how to start oral contraceptive pills based on the user's menstrual cycle. It shows a hand placing a day label strip above a pill pack labeled with days of the week and instructs users to begin on Sunday or the first day of their period, taking pills from left to right weekly.*

FDA Label Image

8 (Image 08)

A boxed warning text panel stating that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. It highlights that the risk rises with age and heavy smoking (15 or more cigarettes per day) and is notably high in women over 35 years old. It advises women who use oral contraceptives not to smoke.*

FDA Label Image

9 (Image 09)

A black-and-white text panel warning about the increased risk of serious cardiovascular side effects from oral contraceptive use associated with cigarette smoking. The warning specifically highlights that the risk increases with age and heavy smoking, particularly in women over 35 years old, and advises women using oral contraceptives not to smoke.*

FDA Label Image

10 (Image 10)

Table presenting the annual number of birth-related or method-related deaths per 100,000 nonsterile women by fertility control method and age group. Methods include no fertility control, oral contraceptives (smoker and non-smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence. Death rates are given for age groups 15-19, 20-24, 25-29, 30-34, 35-39, and 40-44, with footnotes indicating if deaths are birth or method related.*

FDA Label Image

11 (Image 11)

An instructional illustration showing how to use the Larin Fe 1.5/30 oral contraceptive pill kit by Northstar Rx LLC. It includes guidance for day-1 starters to align the day label strip with the first day of the menstrual period. The diagram shows the weekly pill sequence, indicating to take pills left to right each week, with color-coded pill days and an example of the day label placement on the pill pack.*

FDA Label Image

12 (Image 12)

FDA Label Image

13 (Image 13)

The packaging label for Larin Fe 1.5/30, a human prescription drug kit containing Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets. The label shows box panels with the product name and active ingredients in black and orange text. It notes the kit contains six blister cards of 28 tablets each. Manufacturer is Northstar Rx LLC with NDC 16714-405-04. The label includes usage warnings, barcode, and a decorative orange flower image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.